Central neurocytoma
Showing 1 - 25 of 7,163
Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma Trial in Worldwide (dabrafenib, trametinib)
Recruiting
- Diffuse Astrocytoma
- +22 more
-
Phoenix, Arizona
- +26 more
Jan 27, 2023
Low-Grade Glioma, Recurrent Low-Grade Glioma, Progressive Low-Grade Glioma Trial in Memphis (Mirdametinib)
Recruiting
- Low-Grade Glioma
- +2 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 24, 2022
Childhood Brain Tumors Trial in Houston (Antineoplaston therapy (Atengenal + Astugenal))
Completed
- Childhood Brain Tumors
- Antineoplaston therapy (Atengenal + Astugenal)
-
Houston, TexasBurzynski Clinic
Mar 3, 2022
Subacromial Pain Syndrome, Central Sensitisation Trial in Adana (Assessment of hypersensitivity)
Completed
- Subacromial Pain Syndrome
- Central Sensitisation
- Assessment of hypersensitivity
-
Adana, TurkeyCukurova University
Nov 15, 2023
Central Insulin Resistance, Diabetes, Type 2, PreDiabetes Trial (Human nasal insulin, Placebo)
Not yet recruiting
- Central Insulin Resistance
- +2 more
- Human nasal insulin
- Placebo
- (no location specified)
May 12, 2023
Central Sensitization, Manual Therapy Trial in Ankara (manual therapy, conventional physiotherapy)
Not yet recruiting
- Central Sensitization
- Manual Therapy
- manual therapy
- conventional physiotherapy
-
Ankara, Select State, Turkey
- +1 more
Jul 6, 2023
Central Sensitisation, Subacromial Impingement Syndrome Trial in Istanbul (Injection of 1 CC Betamethasone Dipropionate +
Recruiting
- Central Sensitisation
- Subacromial Impingement Syndrome
- Injection of 1 CC Betamethasone Dipropionate + Betamethasone Sodium Phosphate (Diprospan) and 4 cc 2% Prilocaine (Priloc)mixture into the subacromial space
-
Istanbul, TurkeySultan Abdülhamid Han Research and Training Hospital
Jun 23, 2023
Skin Injury Trial in Istanbul (SECURE Care Bundle, Standart Care)
Not yet recruiting
- Skin Injury
- SECURE Care Bundle
- Standart Care
-
Istanbul, Şişli, TurkeyIstanbul University- Cerrahpaşa
Nov 5, 2023
Thyroid Cancer, Recurrence Trial in Beijing (prophylactic central neck dissection)
Recruiting
- Thyroid Cancer
- Recurrence
- prophylactic central neck dissection
-
Beijing, Beijing, ChinaCancer Hospital, Chinese Academy of Medical Science
Oct 8, 2023
Hypertension, Chronic Kidney Disease, Blood Pressure Trial in Montréal (Brachial and Central BP measurements with Mobil-o-Graph
Recruiting
- Hypertension
- +2 more
- Brachial and Central BP measurements with Mobil-o-Graph NG device (IEM), WatchBP Office device (Microlife), BP+ device (Uscom) and Oscar 2 with SphygmoCor inside device (SunTech)
-
Montréal, Quebec, CanadaHôpital du Sacré-Coeur de Montréal
Jul 25, 2023
Parkinson Disease Trial in Toulouse (Clinical assessment, Pain characteristics assessment, MRI)
Not yet recruiting
- Parkinson Disease
- Clinical assessment
- +5 more
-
Toulouse, Haute-Garonne, FranceCentre Hospitalier Universitaire de Toulouse
Aug 22, 2023
Central Apnoea Monitor Study
Recruiting
- Sleep Apnea
-
Sheffield, United KingdomClinical Research Facility, Sheffield Children's Hospital
Oct 16, 2023
Mottling Score and Central Venous Oxygen Saturation in Septic
Recruiting
- Central Oxygen Saturation
- +3 more
-
Erzi̇ncan, TurkeyNurcan Kutluer Karaca
Jan 11, 2023
Temporomandibular Joint Disorders, Pain Trial in Trabzon
Recruiting
- Temporomandibular Joint Disorders
- Pain
-
Trabzon, TurkeyKaradeniz Technical University
Aug 14, 2023
Central Line Complication, Thrombosis, Venous Trial in Hong Kong (Thrombin generation assay)
Not yet recruiting
- Central Line Complication
- Thrombosis, Venous
- Thrombin generation assay
-
Hong Kong, Hong KongQueen Mary Hospital
Oct 20, 2023
Neuropathic Complaints and Central Sensitization in Fibromyalgia
Recruiting
- Central Sensitisation
- +2 more
- Central sensitization inventory
- +5 more
-
Istanbul, Uskudar, TurkeyUniversity of Health Sciences
Jan 18, 2023
Central Line-associated Bloodstream Infection (CLABSI) Trial in Utrecht (TauroLock-Hep100 (taurolidine 1.35%, citrate 4%,
Recruiting
- Central Line-associated Bloodstream Infection (CLABSI)
- TauroLock-Hep100 (taurolidine 1.35%, citrate 4%, heparin 100 IU/mL)
- Heparin lock (heparin 100 IU/mL)
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Feb 13, 2023
Schizophrenia, Central Obesity Trial in Shanghai (Acupuncture)
Recruiting
- Schizophrenia
- Central Obesity
- Acupuncture
-
Shanghai, Shanghai, China
- +1 more
Apr 16, 2023
Patterns and Clinical Outcomes in Central Nervous System
Completed
- Central Nervous System Tuberculosis
-
Wuhan, Hubei, China
- +1 more
Aug 25, 2023
Apnea Trial in Huai'an (polysomnography)
Recruiting
- Apnea
- polysomnography
-
Huai'an, Jiangsu, ChinaDepartment Of Respiratory Medicine,Huai'an First People's Hospit
May 11, 2023
Central Precocious Puberty Trial in Gyeonggi-do (Leuprolide Acetate 11.25 MG/ML)
Recruiting
- Central Precocious Puberty
- Leuprolide Acetate 11.25 MG/ML
-
Gyeonggi-do, Korea, Republic ofAjou University medical center
Aug 29, 2023
Back Pain Trial (Pilates Exercise, Mckenzie Exercise)
Not yet recruiting
- Back Pain
- Pilates Exercise
- Mckenzie Exercise
- (no location specified)
Jun 1, 2023
Central Retinal Vein Occlusion With Macular Edema Trial in Peshawar (Group A)
Completed
- Central Retinal Vein Occlusion With Macular Edema
- Group A
-
Peshawar, KPK, PakistanHayatabad Medical Complex
Apr 3, 2022
Edentulous Jaw Trial in Shanghai (Dynamic navigation, Static template)
Recruiting
- Edentulous Jaw
- Dynamic navigation
- Static template
-
Shanghai, ChinaShanghai Ninth People's Hospital
Sep 20, 2023